Business Context and Reporting Period
This Form 8-K Current Report was filed by Pulmatrix, Inc. on September 25, 2020. The filing reports a corporate governance event: the appointment of a new director to the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and associated compensation.
Material Changes
The primary material change is the appointment of Todd Bazemore as a Class I director, effective October 1, 2020. He was also appointed to the nomination and corporate governance committee.
Guidance, Outlook, and Compensation Details
There is no financial guidance or outlook provided in this filing. The document details the compensation package for the new director:
- Stock Options: Grant of 30,000 shares of common stock options at the closing price on the grant date. Vesting is 25% on the first anniversary, with the remainder vesting monthly over the subsequent 36 months.
- Director Retainer: Annual retainer of $30,000, payable quarterly.
- Committee Retainer: Additional annual retainer of $5,000 for committee service, payable quarterly.
Key Facts for Investor Verification
- Verify the effective date of Todd Bazemore's directorship (October 1, 2020).
- Confirm the total annual cash compensation ($35,000) and the vesting schedule for the 30,000 stock options.
- Review the attached press release (Exhibit 99.1) for additional context on the appointment.